U.S. Drug Testing Market Size & Outlook, 2025-2030
The drug testing market in the United States is expected to reach a projected revenue of US$ 8,637.0 million by 2030. A compound annual growth rate of 4.8% is expected of the United States drug testing market from 2025 to 2030.
Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories
Other key industry trends
In terms of revenue, U.S. accounted for 47.2% of the global drug testing market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In North America, U.S. drug testing market is projected to lead the regional market in terms of revenue in 2030.
U.S. is the fastest growing regional market in North America and is projected to reach USD 8,598.7 million by 2030.
Alcohol consumption is one of the major factors expected to contribute to the U.S. drug testing market during the forecast period. According to a study published by The Pennsylvania State University, in 2021–2022, an estimated 63% of U.S. adults over 18 years and older consumed alcohol.
Furthermore, according to data published by the National Center for Drug Abuse Statistics (NCDAS) in February 2023, around 46% of the U.S. drug users have reported consumption of cannabis and prescription stimulants, which includes 10% of the population consuming cocaine, 36% using opioids & methamphetamine, and 15% heroin.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Testing Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 35.96% in 2024.
Horizon Databook has segmented the U.S. drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
Alcohol consumption is one of the major factors expected to contribute to the U.S. drug testing market during the forecast period. According to a study published by The Pennsylvania State University, in 2021–2022, an estimated 63% of U.S. adults over 18 years and older consumed alcohol.
Furthermore, according to data published by the National Center for Drug Abuse Statistics (NCDAS) in February 2023, around 46% of the U.S. drug users have reported consumption of cannabis and prescription stimulants, which includes 10% of the population consuming cocaine, 36% using opioids & methamphetamine, and 15% heroin.
U.S. Drug Testing Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables
Instruments
Rapid Testing Devices
Services
U.S. Drug Testing Market Sample Type Outlook (Revenue, USD Million , 2018-2030)
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples
U.S. Drug Testing Market Drug Type Outlook (Revenue, USD Million , 2018-2030)
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others
U.S. Drug Testing Market End Use Outlook (Revenue, USD Million , 2018-2030)
Drug Testing Laboratories
Workplaces
Hospitals
Other
Reasons to subscribe to Drug Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Testing Market Outlook databook
Our clientele includes a mix of Drug Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Drug Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Drug Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.